2018

1. Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial

   Journal of Bone and Mineral Research, Vol. 33, Núm. 5, pp. 783-794

2. Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

   The Lancet, Vol. 391, Núm. 10117, pp. 230-240